Marianna Deway Andrade Dracoulakis
Overview
Explore the profile of Marianna Deway Andrade Dracoulakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Barros E Silva P, Furtado R, de Alcantara Chaud M, Macedo A, Bronhara B, Damiani L, et al.
J Thromb Thrombolysis
. 2024 May;
57(6):1031-1039.
PMID: 38762708
Therapeutic anticoagulation showed inconsistent results in hospitalized patients with COVID-19 and selection of the best patients to use this strategy still a challenge balancing the risk of thrombotic and hemorrhagic...
2.
Tavares C, de Azevedo L, Rea-Neto A, Campos N, Amendola C, Bergo R, et al.
Crit Care Sci
. 2023 Dec;
35(3):256-265.
PMID: 38133155
Background: Critical illness is a major ongoing health care burden worldwide and is associated with high mortality rates. Sodium-glucose cotransporter-2 inhibitors have consistently shown benefits in cardiovascular and renal outcomes....
3.
Arns B, Agani C, Sesin G, Horvath J, Fogazzi D, Silva F, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 Jul;
3(1):e102.
PMID: 37396195
[This corrects the article DOI: 10.1017/ash.2023.136.].
4.
Arns B, Agani C, Sesin G, Horvath J, Fogazzi D, Silva F, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 May;
3(1):e79.
PMID: 37179767
Objective: Data are scarce regarding hospital infection control committees and compliance with infection prevention and control (IPC) recommendations in Brazil, a country of continental dimensions. We assessed the main characteristics...
5.
Tomazini B, Nassar Jr A, Lisboa T, de Azevedo L, Veiga V, Mangas Catarino D, et al.
Rev Bras Ter Intensiva
. 2023 Mar;
34(4):418-425.
PMID: 36888821
Objective: To describe the IMPACTO-MR, a Brazilian nationwide intensive care unit platform study focused on the impact of health care-associated infections due to multidrug-resistant bacteria. Methods: We described the IMPACTO-MR...
6.
Lopes R, de Barros E Silva P, Furtado R, Macedo A, Bronhara B, Damiani L, et al.
Lancet
. 2021 Jun;
397(10291):2253-2263.
PMID: 34097856
Background: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the...
7.
Hajjar L, Costa I, Lopes M, Hoff P, Diz M, Fonseca S, et al.
Arq Bras Cardiol
. 2020 Dec;
115(5):1006-1043.
PMID: 33295473
No abstract available.
8.
Dracoulakis M, Gurbel P, Cattaneo M, Martins H, Nicolau J, Kalil Filho R
Arq Bras Cardiol
. 2019 Aug;
113(3):357-363.
PMID: 31432979
Background: High platelet reactivity (HPR) during therapy with acetylsalicylic acid (ASA) is a poor prognostic factor in acute coronary syndromes (ACS). The prevalence of HPR during ACS is greater than...
9.
Oliveira G, Negri F, Clausell N, Moreira M, de Souza O, Macedo A, et al.
Arq Bras Cardiol
. 2019 Jul;
112(6):713-714.
PMID: 31314823
No abstract available.
10.
Berwanger O, de Barros E Silva P, Barbosa R, Precoma D, Figueiredo E, Hajjar L, et al.
Am Heart J
. 2016 Nov;
184:88-96.
PMID: 27892891
Methods: We randomized 648 statin-naïve patients who were scheduled for noncardiac surgery and were at risk for a major vascular complication. Patients were randomized to a loading dose of atorvastatin...